Just like what Dr Geert Van Bossche warned of...
New Research Finds Merck’s COVID-19 Antiviral Molnupiravir Drives Viral Mutations
“Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts by inducing mutations in the virus genome during replication.
Here we show that SARS-CoV-2 sequencing databases contain extensive evidence of molnupiravir mutagenesis.
We identify a mutational spectrum, with preferred nucleotide contexts, from viruses in patients known to have been treated with molnupiravir and show that its signature matches that seen in these long branches, in some cases with onwards transmission of molnupiravir-derived lineages.”
via https://www.medrxiv.org/content/10.1101/2023.01.26.23284998v4.full.pdf
@TheStarkNakedBrief
New Research Finds Merck’s COVID-19 Antiviral Molnupiravir Drives Viral Mutations
“Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts by inducing mutations in the virus genome during replication.
Here we show that SARS-CoV-2 sequencing databases contain extensive evidence of molnupiravir mutagenesis.
We identify a mutational spectrum, with preferred nucleotide contexts, from viruses in patients known to have been treated with molnupiravir and show that its signature matches that seen in these long branches, in some cases with onwards transmission of molnupiravir-derived lineages.”
via https://www.medrxiv.org/content/10.1101/2023.01.26.23284998v4.full.pdf
@TheStarkNakedBrief
Comments
Be the first to add a comment
Log in to comment